{
    "medicine_id": "cea13070d8b51073e5a42c129b71d45f858967c5",
    "platform_id": "DB05934",
    "metadata": {
        "name": "Besponsa 0 25 mg 1mL Injection powder lyophilized for solution",
        "composition": "0 25 mg 1mL CTCE 0214",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in adverse effects chemotherapy blood blood forming organ disorders unspecified cancer tumors unspecified neutropenics and vascular diseases",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}